Equine Influenza: Prevention and Control

2012 ◽  
Vol 7 (3) ◽  
pp. 281-288
Author(s):  
Takashi Yamanaka ◽  
◽  
Takashi Kondo ◽  
Tomio Matsumura

Equine influenza (EI) is a highly contagious selflimiting respiratory disease in horses that is caused by equine influenza virus (EIV) infection. EIV is presented by horses worldwide and has a huge financial impact on the horse industry in many countries. Although an outbreak of EI can be controlled by prior immunization by using vaccination, the efficacy of the vaccine is influenced by antigenic differences between epidemic strains and vaccine strains. Thus, to keep the vaccine effective, the vaccine strains should be reviewed periodically on the basis of global surveillance, such as the epidemiological report issued annually in the bulletin of the World Organization for Animal Health. Once an outbreak occurs, sanitary management, including the restriction of horse movement, should be conducted to eliminate the source of the causative virus and protect susceptible horses. The rapid identification of EIV in respiratory tract secretions enables the prompt administration of sanitary management. Although commercially available rapid antigen detection tests should be improved in terms of sensitivity, one of the tests (ESPLINE Flu A+B) worked as a convenient method for the rapid diagnosis and screening of a number of horses for EI during the 2007 outbreak in Japan, in addition to laboratory tests such as virus isolation. A more sensitive test must be developed that can be performed easily without special equipment or technical expertise.

2018 ◽  
Vol 6 (12) ◽  
Author(s):  
Manabu Nemoto ◽  
Takashi Yamanaka ◽  
Hiroshi Bannai ◽  
Koji Tsujimura ◽  
Hiroshi Kokado

ABSTRACT We sequenced the eight segments of influenza A virus strains A/equine/Ibaraki/1/2007 and A/equine/Yokohama/aq13/2010, which are strains of the Florida sublineage clades 1 and 2 of the H3N8 subtype equine influenza virus. These strains have been used as vaccine strains in Japan since 2016 in accordance with World Organization for Animal Health (OIE) recommendations.


Viruses ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 933
Author(s):  
Pilar Blanco-Lobo ◽  
Laura Rodriguez ◽  
Stephanie Reedy ◽  
Fatai S. Oladunni ◽  
Aitor Nogales ◽  
...  

Vaccination remains the most effective approach for preventing and controlling equine influenza virus (EIV) in horses. However, the ongoing evolution of EIV has increased the genetic and antigenic differences between currently available vaccines and circulating strains, resulting in suboptimal vaccine efficacy. As recommended by the World Organization for Animal Health (OIE), the inclusion of representative strains from clade 1 and clade 2 Florida sublineages of EIV in vaccines may maximize the protection against presently circulating viral strains. In this study, we used reverse genetics technologies to generate a bivalent EIV live-attenuated influenza vaccine (LAIV). We combined our previously described clade 1 EIV LAIV A/equine/Ohio/2003 H3N8 (Ohio/03 LAIV) with a newly generated clade 2 EIV LAIV that contains the six internal genes of Ohio/03 LAIV and the HA and NA of A/equine/Richmond/1/2007 H3N8 (Rich/07 LAIV). The safety profile, immunogenicity, and protection efficacy of this bivalent EIV LAIV was tested in the natural host, horses. Vaccination of horses with the bivalent EIV LAIV, following a prime-boost regimen, was safe and able to confer protection against challenge with clade 1 (A/equine/Kentucky/2014 H3N8) and clade 2 (A/equine/Richmond/2007) wild-type (WT) EIVs, as evidenced by a reduction of clinical signs, fever, and virus excretion. This is the first description of a bivalent LAIV for the prevention of EIV in horses that follows OIE recommendations. In addition, since our bivalent EIV LAIV is based on the use of reverse genetics approaches, our results demonstrate the feasibility of using the backbone of clade 1 Ohio/03 LAIV as a master donor virus (MDV) for the production and rapid update of LAIVs for the control and protection against other EIV strains of epidemiological relevance to horses.


2018 ◽  
Vol 74 (1) ◽  
pp. 5992-2018
Author(s):  
AGNIESZKA ŻAK ◽  
NATALIA SIWIŃSKA ◽  
BARBARA BAŻANÓW

The aim of the study was to determine the presence of the equine influenza virus (EIV), the equine arteritis virus (EAV), and the equine herpesvirus (EHV) in the conjunctival sac of clinically healthy horses. Fifty horses of both sexes and various breeds and ages were included in the study. Virus isolation was carried out in cell cultures (the Madin-Darby canine kidney, green monkey kidney and rabbit kidney cells) from conjunctival swabs. The hemagglutination assay was carried out in order to identify EI viral amplification. The study revealed no presence of the above listed viruses in the conjunctival sac of clinically healthy horses. .


2011 ◽  
Vol 2011 ◽  
pp. 1-14 ◽  
Author(s):  
Kuldeep Dhama ◽  
Mahesh Mahendran ◽  
Ruchi Tiwari ◽  
Shambhu Dayal Singh ◽  
Deepak Kumar ◽  
...  

Tuberculosis, a List B disease of World Organization for Animal Health, caused byM. aviumorM. genavensepredominantly affects poultry and pet or captive birds. Clinical manifestations in birds include emaciation, depression and diarrhea along with marked atrophy of breast muscle. Unlike tuberculosis in animals and man, lesions in lungs are rare. Tubercular nodules can be seen in liver, spleen, intestine and bone marrow. Granulomatous lesion without calcification is a prominent feature. The disease is a rarity in organized poultry sector due to improved farm practices, but occurs in zoo aviaries. Molecular techniques like polymerase chain reaction combined with restriction fragment length polymorphism and gene probes aid in rapid identification and characterization of mycobacteria subspecies, and overcome disadvantages of conventional methods which are slow, labour intensive and may at times fail to produce precise results.M. avium subsp. aviumwith genotypeIS901+ andIS1245+ causes infections in animals and human beings too. The bacterium causes sensitivity in cattle to the tuberculin test. The paper discusses in brief theM. aviuminfection in birds, its importance in a zoonotic perspective, and outlines conventional and novel strategies for its diagnosis, prevention and eradication in domestic/pet birds and humans alike.


Pathogens ◽  
2019 ◽  
Vol 8 (2) ◽  
pp. 62 ◽  
Author(s):  
Jacinta Gahan ◽  
Marie Garvey ◽  
Rozanah Asmah Abd Samad ◽  
Ann Cullinane

In August 2015, Malaysia experienced an outbreak of acute respiratory disease in racehorses. Clinical signs observed were consistent with equine influenza (EI) infection. The index cases were horses recently imported from New Zealand. Rapid control measures, including temporary cancellation of racing, were implemented to minimize the impact of the outbreak. By November, the disease outbreak was resolved, and movement restrictions were lifted. The aim of this study was to confirm the clinical diagnosis and characterize the causal virus. A pan-reactive influenza type A real-time RT-PCR was used for confirmatory diagnosis. Antigenic characterization by haemagglutinin inhibition using a panel of specific ferret antisera indicated that the causal virus belonged to clade 1 of the H3N8 Florida sub-lineage. The genetic characterization was achieved by the whole genome sequencing of positive nasal swabs from clinically affected animals. Pylogenetic analysis of the haemagglutinin (HA) and neuraminidase (NA) genes demonstrated ≥99% homology with several EI strains that had recently circulated in the USA and Japan. The antigenic and genetic characterization did not indicate that the current World Organisation for Animal Health (OIE) recommendations for EI vaccine composition required modification.


2010 ◽  
Vol 18 (1) ◽  
pp. 143-149 ◽  
Author(s):  
Jun-Jun Shao ◽  
Chung Kai Wong ◽  
Tong Lin ◽  
Shuk Kwan Lee ◽  
Guo-Zheng Cong ◽  
...  

ABSTRACTIn order to develop a completely safe immunogen to replace the traditional inactivated vaccine, a tandem-repeat multiple-epitope recombinant vaccine against foot-and-mouth disease (FMD) virus (FMDV) type O was developed. It contained three copies each of residues 141 to 160 and 200 to 213 of VP1 of the O/China/99 strain of FMDV coupled with a swine immunoglobulin G heavy-chain constant region (scIgG). The data showed that the multiple-epitope recombinant vaccine elicited high titers of anti-FMDV specific antibodies in swine at 30 days postvaccination (dpv) and conferred complete protection against a challenge with 10350% swine infective doses of the O/China/99 strain. The anti-FMDV specific antibody titers were not significantly different between the multiple-epitope recombinant vaccine and the traditional vaccine (ttest,P> 0.05). The number of 50% pig protective doses was 6.47, which is higher than the number recommended by the World Organization for Animal Health. The multiple-epitope recombinant vaccine resulted in a duration of immunity of at least 6 months. We speculate that the multiple-epitope recombinant vaccine is a promising vaccine that may replace the traditional inactivated vaccine for the prevention and control of FMD in swine in the future.


2013 ◽  
Vol 16 (4) ◽  
pp. 663-669
Author(s):  
W. Rozek ◽  
M. Kwasnik ◽  
J.F. Zmudzinski

AbstractChanges in the level of cellular proteins in cells inoculated with equine influenza virus H7N7 and H3N8 were studied with microarray technique. H3N8 induced pro-apoptotic proteins while H7N7 induced both pro- as well as anti-apoptotic factors. The higher level of some cytoskeleton components and proteins involved in the protein quality control was recorded. Relatively high number of proteins involved in the regulation of transcription was down-regulated. The pattern of changes observed for H7N7 and H3N8 may reflect differences in the biological properties of both serotypes.


Sign in / Sign up

Export Citation Format

Share Document